[
  {
    "ts": "2025-11-18T09:45:15+00:00",
    "headline": "Stifel Maintains Hold Rating on Vertex (VRTX), Keeps $445 Price Target",
    "summary": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best gene-editing stocks to buy according to hedge funds. On November 10, Stifel maintained a Hold rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). The firm also kept its price target at $445 for the stock. Stifel’s analysts referenced Vertex’s presentation of povetacicept (a dual BAFF/APRIL inhibitor) open-label Phase […]",
    "url": "https://finance.yahoo.com/news/stifel-maintains-hold-rating-vertex-094515901.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "c9226120-d140-341b-9934-10755b483139",
      "content": {
        "id": "c9226120-d140-341b-9934-10755b483139",
        "contentType": "STORY",
        "title": "Stifel Maintains Hold Rating on Vertex (VRTX), Keeps $445 Price Target",
        "description": "",
        "summary": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best gene-editing stocks to buy according to hedge funds. On November 10, Stifel maintained a Hold rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). The firm also kept its price target at $445 for the stock. Stifel’s analysts referenced Vertex’s presentation of povetacicept (a dual BAFF/APRIL inhibitor) open-label Phase […]",
        "pubDate": "2025-11-18T09:45:15Z",
        "displayTime": "2025-11-18T09:45:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/ebfc00a4e36a86ae93bae37394969574",
          "originalWidth": 300,
          "originalHeight": 300,
          "caption": "tifel Maintains Hold Rating on Vertex (VRTX), Keeps $445 Price Target",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OrUjEhTQ558OAB4v1CuhoA--~B/aD0zMDA7dz0zMDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/ebfc00a4e36a86ae93bae37394969574.cf.webp",
              "width": 300,
              "height": 300,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0loC6Itwxz._frgmtnABlQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/ebfc00a4e36a86ae93bae37394969574.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/stifel-maintains-hold-rating-vertex-094515901.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stifel-maintains-hold-rating-vertex-094515901.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]